Inventor
SCHOEBERL BIRGIT
US14 patents
⚠️ This page may combine multiple inventors who share the name “SCHOEBERL BIRGIT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SILVER CREEK PHARMACEUTICALS INC
5 patentsUS10407512B2Sep 10, 2019
Bi-specific fusion proteins
SILVER CREEK PHARMACEUTICALS INC9 citations91
US10988547B2Apr 27, 2021
Bi-specific fusion proteins
SILVER CREEK PHARMACEUTICALS INC6 citations83
US10858450B2Dec 8, 2020
Bi-specific fusion proteins
SILVER CREEK PHARMACEUTICALS INC6 citations82
US11814443B2Nov 14, 2023
Bi-specific fusion proteins
SILVER CREEK PHARMACEUTICALS INC1 citations72
US11673970B2Jun 13, 2023
Bi-specific fusion proteins
SILVER CREEK PHARMACEUTICALS INC1 citations71
MERRIMACK PHARMACEUTICALS INC
4 patentsUS7846440B2Dec 7, 2010
Antibodies against ErbB3 and uses thereof
MERRIMACK PHARMACEUTICALS INC92 citations98
US9718892B2Aug 1, 2017
Method of treating myocardial infarction by administering a bi-specific fusion protein
MERRIMACK PHARMACEUTICALS INC12 citations92
US9982060B2May 29, 2018
Bi-specific fusion proteins
MERRIMACK PHARMACEUTICALS INC9 citations91
US9487588B2Nov 8, 2016
Antibodies against the ectodomain of ERBB3 and uses thereof
MERRIMACK PHARMACEUTICALS INC4 citations83
SCHOEBERL BIRGIT
3 patentsUS8961966B2Feb 24, 2015
Antibodies against ERBB3 and uses thereof
SCHOEBERL BIRGIT20 citations91
US8691225B2Apr 8, 2014
Antibodies against the ectodomain of ErbB3 and uses thereof
SCHOEBERL BIRGIT26 citations91
US8623592B2Jan 7, 2014
Methods and systems for predicting response of cells to a therapeutic agent
SCHOEBERL BIRGIT9 citations78